botrocetin

Known as: Bothrops venom factor, venom coagglutinin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2016
05101519822016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Binding of von Willebrand factor (VWF) to the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates a signaling cascade… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Ultralarge von Willebrand factor (ULVWF) multimers have been implicated in the pathogenesis of the catastrophic microangiopathic… (More)
Is this relevant?
2002
2002
The A1 domain of von Willebrand factor (vWF) mediates platelet adhesion to sites of vascular injury by binding to the platelet… (More)
Is this relevant?
2001
2001
Under conditions of high shear stress, both hemostasis and thrombosis are initiated by the interaction of the platelet membrane… (More)
Is this relevant?
1991
1991
We have used proteolytic fragments and overlapping synthetic peptides to define the domain of von Willebrand factor (vWF) that… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1990
1990
We have evidence that ristocetin and botrocetin mediate binding of von Willebrand Factor (vWF) to platelet glycoprotein Ib (GPIb… (More)
Is this relevant?
1989
1989
Botrocetin (venom coagglutinin) induces binding of von Willebrand factor (vWF) to platelet glycoprotein Ib (GPIb), resulting in… (More)
  • figure 1
  • table 1
  • figure 4
  • figure 2
  • figure 3
Is this relevant?
1989
1989
Interaction of von Willebrand factor (vWF) with its platelet receptor only occurs in vitro in the presence of a modulator such as… (More)
Is this relevant?
1983
1983
Botrocetin, originally called venom coagglutinin, is a Bothrops factor that causes aggregation of blood platelets in the presence… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?